Allergy and Infectious Diseases Research
Open Opportunities (33)
Live Grants.gov opportunities funded under this program — you can apply now.
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) Deadline: Nov 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) Deadline: Nov 10, 2026
- HIV/AIDS Clinical Trials Network Laboratory Centers Deadline: Jan 22, 2027
- HIV/AIDS Clinical Trials Network Statistical and Data Management Centers Deadline: Jan 22, 2027
- Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases Deadline: Jan 22, 2027
- HIV/AIDS Clinical Trials Network Clinical Trials Units Deadline: Jan 22, 2027
- HIV/AIDS Clinical Trials Network Leadership and Operations Centers Deadline: Jan 22, 2027
- Collaborative Network for Clinical Research on Immune Tolerance Deadline: Jan 29, 2027
- Translational Centers Using Microphysiologic Systems for Infectious Diseases Deadline: Jan 29, 2027
- Accelerating Research and Development of Next Generation Vaccines against Malaria – a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) Deadline: Feb 11, 2027
- Asthma and Allergic Diseases Cooperative Research Centers Deadline: May 21, 2027
- Translational Transplantation Tolerance Cooperative Study Group Deadline: May 21, 2027
- Improved Drug Susceptibility Testing (DST) for Mycobacteria Deadline: May 28, 2027
- Childhood Asthma in Urban Settings Clinical Research Network Deadline: May 28, 2027
- Clinical Data, Safety and Statistical Centers (CDSSC) Deadline: Jun 1, 2027
- Immune Drivers of Autoimmune Disease Deadline: Jun 11, 2027
- Centers for Research on Neglected Infectious Diseases Deadline: Jun 15, 2027
- Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories Deadline: Sep 30, 2027
- Clinical Trials in Organ Transplantation in Children and Adults Deadline: Sep 30, 2027
- The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes Deadline: Oct 13, 2027
- Partnerships for Advancing Development of Diagnostics for Infectious Diseases Deadline: Oct 14, 2027
- LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) Deadline: Oct 18, 2027
- Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products – Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 – Clinical Trial Not Allow Deadline: Dec 23, 2027
- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) Deadline: Jan 7, 2028 · up to $150K
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) Deadline: Jan 7, 2028 · up to $375K
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) Deadline: Jan 7, 2028
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed) Deadline: Jul 1, 2028 · up to $400K
- Lasker Clinical Research Scholar’s Program (Si2/R00 Clinical Trial Optional) Deadline: Jul 7, 2028 · up to $499K
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) Deadline: Nov 5, 2028 · up to $300K
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Deadline: May 25, 2029
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Deadline: May 25, 2029
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Deadline: Jul 5, 2029
- Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) Deadline: Jul 12, 2029
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.855 (USAspending.gov).
- Scripps Research Institute 2 awards $285,963,707
- President And Fellows Of Harvard College $246,626,852
- University Of Texas Medical Branch At Galveston $197,316,803
- Duke University $180,737,624
- Trustees Of Boston University $147,765,880
- University Of California, Los Angeles $116,817,868
- University Of Alabama At Birmingham $93,394,862
- Sloan-Kettering Institute For Cancer Research $89,845,851
- Regents Of The University Of California, San Francisco, The $85,436,674
Program Objective
To assist public and private nonprofit institutions and individuals to establish, expand and improve biomedical research and research training in infectious diseases and related areas; to conduct developmental research, to produce and test research materials. To assist public, private and commercial institutions to conduct developmental research, to produce and test research materials, to provide research services as required by the agency for programs in infectious diseases, and controlling disease caused by infectious or parasitic agents, allergic and immunologic diseases and related areas. Projects range from studies of microbial physiology and antigenic structure to collaborative trials of experimental drugs and vaccines, mechanisms of resistance to antibiotics as well as research dealing with epidemiological observations in hospitalized patients or community populations and progress in allergic and immunologic diseases. Because of this dual focus, the program encompasses both basic research and clinical research. Small Business Innovation Research (SBIR) program expands and improves private sector participation in biomedical research. The SBIR Program intends to increase and facilitate private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. The Small Business Technology Transfer (STTR) program stimulates and fosters scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. Research Career Development Awards support the development of scientists during the formative stages of their careers. Individual National Research Service Awards (NRSAs) are made directly to approve applicants for research training in specified biomedical shortage areas. In addition, Institutional National Research Service Awards are made to enable institutions to select and make awards to individuals to receive training under the aegis of their institutional program.
Eligibility
Eligible Applicants
- For-Profit Organization
- Not-for-Profit Organization
- U.S. State Government
- Federally Recognized Tribal Government
- Tribal Government (other)
- Tribally Designated Housing Authority
- Municipality/Township Government
- County Government
- School District
- Foreign Nonprofit Organization
- Foreign For-Profit Organization
Universities, colleges, hospitals, laboratories, and other public or private nonprofit domestic institutions, including State and local units of government, and individuals are eligible to make application for grant support of research by a named principal investigator or a research career development candidate. For-profit organizations are also eligible, with the exception of NRSA. Individual NRSA awardees must be nominated and sponsored by a public or nonprofit private institution having staff and facilities appropriate to the proposed research training program. All NRSA awardees must be citizens or have been admitted to the United States for permanent residence. To be eligible, predoctoral candidates must have completed the baccalaureate degree, and postdoctoral awardees must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D.Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is being proposed and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. or its possessions. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which researches proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Beneficiaries
- Specific Restrictions (Determined at NOFO Level)
Any nonprofit or for-profit organization, company, or institution engaged in biomedical research.
How to Apply
Award Procedure
All accepted applications are reviewed for scientific merit by an appropriate initial review group and a national advisory council. If recommended for approval and a decision to make an award is made, a formal award notice will be sent to the applicant and applicant institution. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
New Non-AIDS research applications: February 1, June 1 and October 1. For Renewal and Supplemental Non-AIDS research grant applications: March 1, July 1, and November 1. For all AIDS research grant applications: January 2, May 1, September 1. Research Career Development Award programs: February 1, June 1, October 1. Individual NRSAs: April 5, August 5, and December 5. Institutional NRSA: September 10. SBIR/STTR: April 1, August 1 and December 1.
Program details & compliance
Description
Provide funding to scientists, universities, and research organizations to study infectious, immunologic, and allergic diseases. These grants and cooperative agreements serve researchers and institutions working to improve public health and protect communities from disease threats. Focus on supporting innovative research that addresses urgent and emerging health challenges, helping to advance scientific knowledge and improve health outcomes for people everywhere.
Mission Categories
Primary: Biology
Other categories:
Research and Development
Use of Funds
Allowed Uses
Beginning with fiscal year 1998, the direct costs awarded in the first year to a research project grant resulting from a competing renewal application will be limited to no more than a 20 percent increase over the direct costs awarded in the last non-competing year of that grant. Research grants provide funds for salaries, equipment, supplies, and travel. They also afford the collateral benefits of enriching the training experience of research workers. Grantees are expected to be judicious in using these funds. The application for a research grant sets forth specific terms and conditions and requires the signatures of the principal investigator and an official authorized to sign for the institution. Scientists and institutions are under an obligation to expend grant funds prudently for the purposes stated in the application and award document. For Research Career Development Awards (RCDAs) the scientists must demonstrate an outstanding research potential for independent research in the sciences related to transplantation, immunology, allergies, and immunological diseases. For National Research Service Awards (NRSAs), each individual who receives NRSA support is obligated upon termination of the award to comply with certain service and payback provisions. SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of the research initiated in Phase I and which are likely to result in commercial products or processes. Only Phase I awardees are eligible to receive Phase II support. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of the Phase II application.
Required Documentation
Research grant applicants must define the objectives, methodology, and facilities for the program, and must present the program director's competence and scientific interest. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant forms PHS 6246-1 and PHS 6246-2 are used to apply for SBIR Phase I and Phase II, respectively. Grant forms PHS 6246-3 and PHS 6246-4 are used to apply for STTR Phase I and Phase II, respectively. Applicants for individual NRSAs must include their academic record, research experience, citizenship, institute sponsorship, and the proposed area and plan of training in their applications. The applicant for an institution must specify the objectives, methodology, and resources for the research training program, the qualifications experience of directing staff, the criteria to be used in selecting individuals for award, and a detailed budget justification for the amount of grant funds requested. For-profit organizations' costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined by HHS Regulations HHS has implemented 2 CFR 200’s administrative requirements, cost principles, and audit requirements under 45 CFR 75.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements